- $93.95m
- $135.95m
- $78.23m
- 16
- 53
- 21
- 20
Annual cashflow statement for OptiNose, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -99.8 | -82.3 | -74.8 | -35.5 | -21.5 |
| Depreciation | |||||
| Non-Cash Items | 12.2 | 11.5 | 12.4 | 2.57 | -3.61 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.096 | -6.78 | -5.76 | 12 | -19.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -86.2 | -76.9 | -67.7 | -20.5 | -44.7 |
| Capital Expenditures | -0.546 | -0.167 | -0.063 | -0.328 | -0.072 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.105 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.546 | -0.062 | -0.063 | -0.328 | -0.072 |
| Financing Cash Flow Items | -0.883 | -0.227 | -0.298 | 0 | -0.206 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 83.8 | 43.3 | 51.4 | 0.3 | 55.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.99 | -33.7 | -16.3 | -20.6 | 10.8 |